{"protocolSection": {"identificationModule": {"nctId": "NCT04738279", "orgStudyIdInfo": {"id": "EH20-288 Cascade Soft Launch"}, "organization": {"fullName": "NorthShore University HealthSystem", "class": "OTHER"}, "briefTitle": "The CASCADE HF Soft Launch and Calibration Phase I and II", "officialTitle": "A Study to Determine the Efficacy of Continuous Ambulatory Wearable Technology and a Cascading Alert System in Reducing 30d Readmission in High Risk Heart Failure Patients"}, "statusModule": {"statusVerifiedDate": "2023-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2020-12-14", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-10-30", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-10-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2021-01-27", "studyFirstSubmitQcDate": "2021-01-29", "studyFirstPostDateStruct": {"date": "2021-02-04", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-12-16", "resultsFirstSubmitQcDate": "2023-02-14", "resultsFirstPostDateStruct": {"date": "2023-02-16", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-10-01", "lastUpdatePostDateStruct": {"date": "2023-10-03", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Nirav Shah", "investigatorTitle": "Medical Director of Quality Innovation and Clinical Practice Analytics, Program Director of Outcomes Research for Quality and Transformation", "investigatorAffiliation": "NorthShore University HealthSystem"}, "leadSponsor": {"name": "NorthShore University HealthSystem", "class": "OTHER"}, "collaborators": [{"name": "physIQ, Inc.", "class": "INDUSTRY"}, {"name": "Carnegie Mellon University", "class": "OTHER"}, {"name": "Northwestern University", "class": "OTHER"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true}, "descriptionModule": {"briefSummary": "Invasive telemonitoring has shown promising results in reducing readmissions and health service utilization, and improving patient outcomes; however, such evidence is lacking for non-invasive telemonitoring. Our proposal is to deploy a wearable solution that predicts physiological perturbation comparable to invasive devices and to perform continuous remote patient monitoring; this will be connected to a structured, cascading, escalation pathway involving home health nurses, advanced practitioner providers, specialists, and surgeons, and has the potential to transform care management in the post-discharge period, where patients are the most vulnerable for readmission."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2", "PHASE3"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "SEQUENTIAL", "primaryPurpose": "OTHER", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 20, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Phase I: Soft Launch (120 days)", "type": "EXPERIMENTAL", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.", "interventionNames": ["Device: Non-Invasive Continuous Remote Patient Monitoring", "Other: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring"]}, {"label": "Phase II: Calibration (210 days)", "type": "EXPERIMENTAL", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes", "interventionNames": ["Device: Non-Invasive Continuous Remote Patient Monitoring", "Other: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring"]}], "interventions": [{"type": "DEVICE", "name": "Non-Invasive Continuous Remote Patient Monitoring", "description": "Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway", "armGroupLabels": ["Phase I: Soft Launch (120 days)", "Phase II: Calibration (210 days)"]}, {"type": "OTHER", "name": "Affective Analysis of Participant Response to Continuous Remote Patient Monitoring", "description": "Survey and qualitative interviewing of participants", "armGroupLabels": ["Phase I: Soft Launch (120 days)", "Phase II: Calibration (210 days)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Attrition Rate", "description": "Drop out from study", "timeFrame": "30 days from patient discharge date"}, {"measure": "Enrollment Rate", "description": "Enrollment rate for entire patient cohort", "timeFrame": "Through study completion, an average of 30 days for each patient"}], "secondaryOutcomes": [{"measure": "Number of Participants With Diuretic Escalation", "description": "Frequency of augmenting diuretic dosage as prescribed by the cardiologist to the patient.", "timeFrame": "30 days from patient discharge date"}, {"measure": "30-day Readmission", "description": "30-day readmission to hospital", "timeFrame": "30 days from patient discharge date"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is an inpatient at NorthShore University HealthSystem\n* Patient is on the heart failure consult list\n* Patient has a history of heart failure\n* Patient received at least one dose of IV diuretics at index hospitalization\n* Patient is discharging with NorthShore Home Health services\n* Symptoms corresponding to New York Heart Association function class II-IV\n* Patient has heart failure with reduced left ventricular ejection fraction (LVEF)\\<40%, or HF with mid-ranged ejection fraction (LVEF 40-50%), or HF with preserved ejection fraction (LVEF\u226550%)\n* Patient is in the top 50% risk of readmission across NorthShore University HealthSystem's CAPE 30-day readmission model\n* Patient is at least 18 years of age\n* Patient is fluent in English\n* Patient agrees to protocol-required procedures\n\nExclusion Criteria:\n\n* Patient has cognitive or physical limitations that, in the opinion of the investigator, limit the patient's ability to maintain patch, phone\n* Patient has allergy to hydrocolloid adhesives\n* Patient has present skin damage preventing them from wearing a study device\n* Patient has renal dysfunction requiring dialysis\n* Pregnancy", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Nirav S Shah, MD, MPH", "affiliation": "NorthShore University HealthSystem", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "NorthShore University HealthSystem Evanston Hospital", "city": "Evanston", "state": "Illinois", "zip": "60201", "country": "United States", "geoPoint": {"lat": 42.04114, "lon": -87.69006}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Recruitment was conducted at Evanston Hospital during December 2020 to October 2021", "groups": [{"id": "FG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "FG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "13"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "BG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "20"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "calculatePct": false, "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "7"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "13"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "8"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "12"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "19"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "16"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "3"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Attrition Rate", "description": "Drop out from study", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days from patient discharge date", "groups": [{"id": "OG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "OG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "2"}]}]}]}, {"type": "PRIMARY", "title": "Enrollment Rate", "description": "Enrollment rate for entire patient cohort", "populationDescription": "Overall number of participants analyzed reflects the number of participants who were screened for phase I and phase II, respectively.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Through study completion, an average of 30 days for each patient", "groups": [{"id": "OG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "OG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "431"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "15"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Diuretic Escalation", "description": "Frequency of augmenting diuretic dosage as prescribed by the cardiologist to the patient.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days from patient discharge date", "groups": [{"id": "OG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "OG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "9"}]}]}]}, {"type": "SECONDARY", "title": "30-day Readmission", "description": "30-day readmission to hospital", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "30 days from patient discharge date", "groups": [{"id": "OG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}, {"id": "OG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "We collected adverse event data over the 30-day participation period for each participant", "eventGroups": [{"id": "EG000", "title": "Phase I: Soft Launch (120 Days)", "description": "The study will conduct a soft launch on the first five HF patients enrolled to finetune process and protocol.\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants", "deathsNumAffected": 0, "deathsNumAtRisk": 5, "seriousNumAffected": 0, "seriousNumAtRisk": 5, "otherNumAffected": 0, "otherNumAtRisk": 5}, {"id": "EG001", "title": "Phase II: Calibration (210 Days)", "description": "After learning from the soft launch and updating the protocol, the study will continue to enroll 15 HF patients for calibration purposes\n\nNon-Invasive Continuous Remote Patient Monitoring: Continuous remote patient monitoring will consist of continuous collection of physiological data and patient status through a non-invasive wearable solution, connected to a structured cascading escalation management pathway\n\nAffective Analysis of Participant Response to Continuous Remote Patient Monitoring: Survey and qualitative interviewing of participants", "deathsNumAffected": 0, "deathsNumAtRisk": 15, "seriousNumAffected": 0, "seriousNumAtRisk": 15, "otherNumAffected": 0, "otherNumAtRisk": 15}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Nirav Shah, MD, MPH", "organization": "NorthShore University HealthSystem", "email": "nshah2@northshore.org", "phone": "(847) 570-1236"}}}, "documentSection": {"largeDocumentModule": {"noSap": true, "largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2022-07-12", "uploadDate": "2022-12-14T02:53", "filename": "Prot_000.pdf", "size": 1372407}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2023-01-12", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}], "browseBranches": [{"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}